Eric Yearley

Company: Bridge Bioscience Corp

Job title: Associate Director

Seminars:

(CASE STUDY) (NEW DATA) Potency Matrix Approach at BridgeBio Gene Therapy & the Development of an In Vitro Potency Assay for Galactose-1-Phosphate Uridylyl¬transferase (GALT) Enzymatic Activity 2:30 pm

• In-Vitro Gene/Protein Expression and Functional Assays and the potency matrix approach at BridgeBio Gene Therapy • Development of an In Vitro Potency Assay for Galactose-1- Phosphate Uridylyl-transferase (GALT) Enzymatic Activity in AAV-Transduced Cells • The (GALT) enzymatic activity assay exhibited a high level of repeatability across multiple executions, demonstrating the utility of the assay…Read more

day: Day One Track A PM